Home>Faculty>Profile

Frank Schwartz, MD, FACE

Professor, Specialty Medicine

Director, ARHI Diabetes Center, HCOM

Edison Biotechnology Institute

schwartz@oucom.ohiou.edu

MD, 1978, West Virginia School of Medicine

Complete Curriculum Vitae (PDF)

 

Research Interests

  

• Toll-Like Receptors (TLR) in the pathogenesis of both type I and type II Diabetes, obesity and atherosclerosis; the effects of C10 to potentially prevent Type I and treat Type II diabetes

• Prevalence of obesity, insulin resistance, diabetes and ASCVD in Appalachia, the barriers to diabetes care in Appalachia, impact of depression on diabetes outcomes, as well as the role of socioeconomic stress to its pathogenesis

• Artificial Intelligence in Medicine to scan large volumes of patient glucose monitoring data, observe recurrent abnormal patterns and then provide intelligent decision support for physicians caring for patients with type I diabetes on insulin pump therapy

Selected Publications

• de Groot M, Kushnick M, Doyle T, Merrill J, McGlynn M, Shubrook J, Schwartz F. A model of community-based behavioral intervention for depression in diabetes: Program ACTIVE. Diabetes Spectrum. 2010, 23(1): 18-25.

• Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F., Shubrook J. Continuous glucose monitoring system in a rural intensive care unit: A pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol. 2010 May 1, 4(3): 636-644. PMID: 20513330 

• McCall KD, Holliday D, Dickerson E, Wallace B, Schwartz AL, Schwartz C, Lewis CJ, Kohn LD, Schwartz FL. Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages. J Endocrinol. 2010 Dec, 207(3): 343-353. PMID: 20813836

• Marling C, Shubrook J, Vernier, S, Wiley, M. Schwartz F. Characterizing Blood Glucose Variability Using New Metrics with Continuous Glucose Monitoring Data.  Journal of Diabetes Science and Technology. 2011 5(4). 871-878.